Use of magnetic resonance imaging in tracking the course and treatment of schizophrenia

References

• Jablensky A, Sartorius N, Ernberg G et al. Schizophrenia: manifestations, incidence and course in different cultures. A WHO ten-country study. Psychol. Med. Monogr. (Suppl. 20), 1–97 (1992).
   PubMedGoogle Scholar
• Jablensky A. Schizophrenia: recent epidemiologic issues. Epidemiol. Rev.17(1), 10–20 (1995).
   PubMed Web of Science ®Google Scholar
• Gottesman II. Schizophrenia genesis: the origins of madness. WH Freeman and Company, NY, USA (1991).
   Google Scholar
• Lehmann HE, Ban TA. The history of the psychopharmacology of schizophrenia. Can. J. Psychiatry42(2), 152–162 (1997).
   PubMed Web of Science ®Google Scholar
• Moller HJ. Antipsychotic agents. Gradually improving treatment from the traditional oral neuroleptics to the first atypical depot. Eur. Psychiatry20(5–6), 379–385 (2005).
   PubMed Web of Science ®Google Scholar
• Salkever D, Slade E, Karakus M. Differential effects of atypical versus typical antipsychotic medication on earnings of schizophrenia patients: estimates from a prospective naturalistic study. Pharmacoeconomics24(2), 123–139 (2006).
   PubMed Web of Science ®Google Scholar
• Sharma T, Antonova L. Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment. Psychiatr. Clin. North Am.26(1), 25–40 (2003).
   PubMed Web of Science ®Google Scholar
• Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch. Gen. Psychiatry60(6), 553–564 (2003).
   PubMed Web of Science ®Google Scholar
• Glassman AH. Schizophrenia, antipsychotic drugs, and cardiovascular disease. J. Clin. Psychiatry66(Suppl. 6), 5–10 (2005).
   PubMed Web of Science ®Google Scholar
• Bottai T, Quintin P, Perrin E. Antipsychotics and the risk of diabetes: a general data review. Eur. Psychiatry20(Supp. 4), S349–S357 (2005).
   PubMed Web of Science ®Google Scholar
• Tandon R, Wolfgang Fleischhacker W. Comparative efficacy of antipsychotics in the treatment of schizophrenia: a critical assessment. Schizophr. Res.79(2–3), 145–155 (2005).
   PubMed Web of Science ®Google Scholar
• Kane JM. Treatment-resistant schizophrenic patients. J. Clin. Psychiatry57(Suppl. 9), 35–40 (1996).
   PubMed Web of Science ®Google Scholar
• Knapp M, Mangalore R, Simon J. The global costs of schizophrenia. Schizophr. Bull.30(2), 279–293 (2004).
   PubMed Web of Science ®Google Scholar
• Thornicroft G, Tansella M, Becker T et al. The personal impact of schizophrenia in Europe. Schizophr. Res.69(2–3), 125–132 (2004).
   PubMed Web of Science ®Google Scholar
• Sharma T, Chitnis X. Brain Imaging in Schizophrenia. Insights and Applications. Remedica Publishing, London, UK (2000).
   Google Scholar
• Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr. Res.49(1–2), 1–52 (2001).
   PubMed Web of Science ®Google Scholar
• Kasai K, Iwanami A, Yamasue H, Kuroki N, Nakagome K, Fukuda M. Neuroanatomy and neurophysiology in schizophrenia. Neurosci. Res.43(2), 93–110 (2002).
   PubMed Web of Science ®Google Scholar
• Pantelis C, Yucel M, Wood SJ et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr. Bull.31(3), 672–696 (2005).
   PubMed Web of Science ®Google Scholar
• Velakoulis D, Wood SJ, Wong MT et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch. Gen. Psychiatry63(2), 139–149 (2006).
   PubMed Web of Science ®Google Scholar
• Nadeau SE, Crosson B. A guide to the functional imaging of cognitive processes. Neuropsychiatry. Neuropsychol. Behav. Neurol.8(3), 143–162 (1995).
   Google Scholar
• Kraepelin E. Dementia Praecox and Paraphrenia. Livingston, Edinburgh, UK (1919).
   Google Scholar
• Beuler E. Dementia Praecox or the Group of Schizophrenias. Zinkin J (Ed.). International University Press, NY, USA (1911; Reprinted 1950).
   Google Scholar
• Gaser C, Schlaug G. Brain structures differ between musicians and non-musicians. J. Neurosci.23(27), 9240–9245 (2003).
   PubMed Web of Science ®Google Scholar
• Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM. Cortical gray matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br. J. Psychiatry172, 527–532 (1998).
   PubMed Web of Science ®Google Scholar
• Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry157(1), 16–25 (2000).
   PubMed Web of Science ®Google Scholar
• Gaser C, Nenadic I, Buchsbaum BR, Hazlett EA, Buchsbaum MS. Ventricular enlargement in schizophrenia related to volume reduction of the thalamus, striatum, and superior temporal cortex. Am. J. Psychiatry161(1), 154–156 (2004).
   PubMed Web of Science ®Google Scholar
• Honea R, Crow TJ, Passingham D, Mackay CE. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am. J. Psychiatry162(12), 2233–2245 (2005).
   PubMed Web of Science ®Google Scholar
• Sharma T, Kumari V. Structural and functional brain abnormalities in first-episode schizophrenia. In: Early Course of Schizophrenia. Sharma T, Harvey PD (Eds), Oxford University Press, UK (2005).
   Google Scholar
• Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry44(7), 660–669 (1987).
   PubMed Web of Science ®Google Scholar
• Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? Br. Med. J.295, 681–682 (1987).
   PubMed Web of Science ®Google Scholar
• Fannon D, Chitnis X, Doku V et al. Features of structural brain abnormality detected in first-episode psychosis. Am. J. Psychiatry157(11), 1829–1834 (2000).
   PubMed Web of Science ®Google Scholar
• Ettinger U, Chitnis XA, Kumari V et al. Magnetic resonance imaging of the thalamus in first-episode psychosis. Am. J. Psychiatry158(1), 116–118 (2001).
   PubMed Web of Science ®Google Scholar
• Sumich A, Chitnis XA, Fannon DG et al. Temporal lobe abnormalities in first-episode psychosis. Am. J. Psychiatry159(7), 1232–1235 (2002).
   PubMed Web of Science ®Google Scholar
• Kim JJ, Crespo-Facorro B, Andreasen NC, O’Leary DS, Magnotta V, Nopoulos P. Morphology of the lateral superior temporal gyrus in neuroleptic naive patients with schizophrenia: relationship to symptoms. Schizophr. Res.60(2–3), 173–181 (2003).
   PubMed Web of Science ®Google Scholar
• Joyal CC, Laakso MP, Tiihonen J et al. The amygdala and schizophrenia: a volumetric magnetic resonance imaging study in first-episode, neuroleptic-naive patients. Biol. Psychiatry54(11), 1302–1304 (2003).
   PubMed Web of Science ®Google Scholar
• Narr KL, Thompson PM, Szeszko P et al. Regional specificity of hippocampal volume reductions in first-episode schizophrenia. NeuroImage21(4), 1563–1575 (2004).
   PubMed Web of Science ®Google Scholar
• Jayakumar PN, Venkatasubramanian G, Gangadhar BN, Janakiramaiah N, Keshavan MS. Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry29(4), 587–591 (2005).
   Google Scholar
• Crespo-Facorro B, Kim JJ, Andreasen NC, Leary DS, Magnotta V. Regional frontal abnormalities in schizophrenia: a quantitative gray matter volume and cortical surface size study. Biol. Psychiatry48(2), 110–119 (2000).
   PubMed Web of Science ®Google Scholar
• Hirayasu Y, Shenton ME, Salisbury DF et al. Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am. J. Psychiatry155(10), 1384–1391 (1998).
   PubMed Web of Science ®Google Scholar
• Molina V, Reig S, Sarramea F et al. Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia. Psych. Res. Neuroimag.124(3), 153–161 (2003).
   Web of Science ®Google Scholar
• DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psych. Res. Neuroimag.74(3), 129–140 (1997).
   PubMed Web of Science ®Google Scholar
• DeLisi LE, Sakuma M, Ge S, Kushner M. Association of brain structural change with the heterogeneous course of schizophrenia from early childhood through five years subsequent to a first hospitalization. Psych. Res. Neuroimag.84(2–3), 75–88 (1998).
   Web of Science ®Google Scholar
• DeLisi LE, Sakuma M, Maurizio AM, Relja M, Hoff AL. Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psych. Res. Neuroimag.130(1), 57–70 (2004).
   PubMed Web of Science ®Google Scholar
• Gharaibeh WS, Rohlf FJ, Slice DE, DeLisi LE. A geometric morphometric assessment of change in midline brain structural shape following a first-episode of schizophrenia. Biol. Psychiatry48(5), 398–405 (2000).
   PubMed Web of Science ®Google Scholar
• Kasai K, Shenton ME, Salisbury DF et al. Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry60(8), 766–775 (2003).
   PubMed Web of Science ®Google Scholar
• Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch. Gen. Psychiatry60(6), 585–594 (2003).
   PubMed Web of Science ®Google Scholar
• Weinberger DR, McClure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch. Gen. Psychiatry59(6), 553–558 (2002).
   PubMed Web of Science ®Google Scholar
• Antonova E, Sharma T, Morris R, Kumari V. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr. Res.70(2–3), 117–145 (2004).
   PubMed Web of Science ®Google Scholar
• Szeszko PR, Gunning-Dixon F, Goldman RS et al. Lack of normal association between cerebellar volume and neuropsychological functions in first-episode schizophrenia. Am. J. Psychiatry160(10), 1884–1887 (2003).
   PubMed Web of Science ®Google Scholar
• Ettinger U, Kumari V, Chitnis XA et al. Volumetric neural correlates of antisaccade eye movements in first-episode psychosis. Am. J. Psychiatry161(10), 1918–1921 (2004).
   PubMed Web of Science ®Google Scholar
• Salgado-Pineda P, Baeza I, Perez-Gomez M et al. Sustained attention impairment correlates to gray matter decreases in first-episode neuroleptic-naive schizophrenic patients. NeuroImage19(2), 365–375 (2003).
   PubMed Web of Science ®Google Scholar
• Flashman LA, Green MF. Review of cognition and brain structure in schizophrenia: profiles, longitudinal course, and effects of treatment. Psychiatr. Clin. North Am.27(1), 1–18 (2004).
   PubMed Web of Science ®Google Scholar
• Premkumar P, Sharma T. Neuropsychologic functioning and structural MRI of the brain in patients with schizophrenia. Expert Rev. Neurotherapeutics5(1), 85–94 (2005).
   PubMedGoogle Scholar
• Weinberger DR, Lipska BK. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr. Res.16(2), 87–110 (1995).
   PubMed Web of Science ®Google Scholar
• Buchsbaum MS. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr. Bull.16(3), 379–389 (1990).
   PubMed Web of Science ®Google Scholar
• Grace AA. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience41(1), 1–24 (1991).
   PubMed Web of Science ®Google Scholar
• Gray JA. Dopamine release in the nucleus accumbens: the perspective from aberrations of consciousness in schizophrenia. Neuropsychologia33(9), 1143–1153 (1995).
   PubMed Web of Science ®Google Scholar
• Gray JA. Integrating schizophrenia. Schizophr. Bull.24(2), 249–266 (1998).
   PubMed Web of Science ®Google Scholar
• O’Donnell P, Grace AA. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schizophr. Bull.24(2), 267–283 (1998).
   PubMed Web of Science ®Google Scholar
• Andreasen NC, Paradiso S, O’Leary DS. “Cognitive dysmetria” as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr. Bull.24(2), 203–218 (1998).
   PubMed Web of Science ®Google Scholar
• Andreasen NC, Nopoulos P, Leary DS, Miller DD, Wassink T, Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol. Psychiatry46(7), 908–920 (1999).
   PubMed Web of Science ®Google Scholar
• Middleton FA, Strick PL. Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. Science266(5184), 458–461 (1994).
   PubMed Web of Science ®Google Scholar
• Schmahmann JD. From movement to thought: anatomic substrates of the cerebellar contribution to cognitive processing. Hum. Brain Mapp.4(3), 174–198 (1996).
   PubMed Web of Science ®Google Scholar
• Schmahmann JD, Sherman JC. Cerebellar cognitive affective syndrome. Int. Rev. Neurobiol.41, 433–440 (1997).
   PubMed Web of Science ®Google Scholar
• Semkovska M, Bedard MA, Stip E. Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives. L’Encephale27(5), 405–415 (2001).
   PubMed Web of Science ®Google Scholar
• Barta PE, Pearlson GD, Powers RE, Richards SS, Tune LE. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am. J. Psychiatry147(11), 1457–1462 (1990).
   PubMed Web of Science ®Google Scholar
• Shenton ME, Kikinis R, Jolesz FA et al. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N. Engl. J. Med.327(9), 604–612 (1992).
   PubMed Web of Science ®Google Scholar
• Kasai K, McCarley RW, Salisbury DF et al. Cavum septi pellucidi in first-episode schizophrenia and first-episode affective psychosis: an MRI study. Schizophr. Res.71(1), 65–76 (2004).
   PubMed Web of Science ®Google Scholar
• DeLisi LE, Hoff AL, Neale C, Kushner M. Asymmetries in the superior temporal lobe in male and female first-episode schizophrenic patients: measures of the planum temporale and superior temporal gyrus by MRI. Schizophr. Res.12(1), 19–28 (1994).
   PubMed Web of Science ®Google Scholar
• Corson PW, Leary DS, Miller DD, Andreasen NC. The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naive and medicated states. Biol. Psychiatry52(9), 855–862 (2002).
   PubMed Web of Science ®Google Scholar
• Gunduz H, Wu H, Ashtari M et al. Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects. Biol. Psychiatry51(10), 801–808 (2002).
   PubMed Web of Science ®Google Scholar
• Chakos M, Lieberman J, Alvir J, Bilder R, Ashtari M. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet345(8947), 456–457 (1995).
   PubMed Web of Science ®Google Scholar
• Chakos MH, Lieberman JA, Bilder RM et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am. J. Psychiatry151(10), 1430–1436 (1994).
   PubMed Web of Science ®Google Scholar
• Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am. J. Psychiatry155(12), 1711–1717 (1998).
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Tollefson GD, Charles C et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry62(4), 361–370 (2005).
   PubMed Web of Science ®Google Scholar
• Garver DL, Holcomb JA, Christensen JD. Cerebral crtical gray expansion associated with two second-generation antipsychotics. Biol. Psychiatry58(1), 62–66 (2005).
   PubMed Web of Science ®Google Scholar
• Shad MU, Muddasani S, Keshavan MS. Prefrontal subregions and dimensions of insight in first-episode schizophrenia – a pilot study. Psych. Res. Neuroimag.146(1), 35–42 (2006).
   PubMed Web of Science ®Google Scholar
• Shad MU, Muddasani S, Prasad K, Sweeney JA, Keshavan MS. Insight and prefrontal cortex in first-episode schizophrenia. NeuroImage22(3), 1315–1320 (2004).
   PubMed Web of Science ®Google Scholar
• Flashman LA, McAllister TW, Johnson SC, Rick JH, Green RL, Saykin AJ. Specific frontal lobe subregions correlated with unawareness of illness in schizophrenia: a preliminary study. J. Neuropsychiatry Clin. Neurosci.13(2), 255–257 (2001).
   PubMed Web of Science ®Google Scholar
• Konicki PE, Kwon KY, Steele V et al. Prefrontal cortical sulcal widening associated with poor treatment response to clozapine. Schizophr. Res.48(2–3), 173–176 (2001).
   PubMed Web of Science ®Google Scholar
• Lieberman J, Chakos M, Wu H et al. Longitudinal study of brain morphology in first-episode schizophrenia. Biol. Psychiatry49(6), 487–499 (2001).
   PubMed Web of Science ®Google Scholar
• Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM. Symptomatic and functional recovery from a first-episode of schizophrenia or schizoaffective disorder. Am. J. Psychiatry161(3), 473–479 (2004).
   PubMed Web of Science ®Google Scholar
• Cahn W, Hulshoff Pol HE, Lems EBTE et al. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch. Gen. Psychiatry59(11), 1002–1010 (2002).
   PubMed Web of Science ®Google Scholar
• Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry160(4), 636–645 (2003).
   PubMed Web of Science ®Google Scholar
• Braff D, Freedman R. Endophenotypes in the studies of the genetics of schizophrenia. In: Neuropsychopharmacology: The 5th Generation of Progress. Davies KL, Charney D, Coyle JT, Nemeroff C (Eds,), Lippincott Williams & Wilkins, Philladelphia, USA 703–716 (2002).
   Google Scholar
• Keltner NL. Genomic influences on schizophrenia-related neurotransmitter systems. J. Nurs. Scholarsh.37(4), 322–328 (2005).
   PubMed Web of Science ®Google Scholar
• Baare WF, Hulshoff Pol HE, Boomsma DI et al. Quantitative genetic modeling of variation in human brain morphology. Cereb. Cortex11(9), 816–824 (2001).
   PubMed Web of Science ®Google Scholar
• Bartley AJ, Jones DW, Weinberger DR. Genetic variability of human brain size and cortical gyral patterns. Brain120(2), 257–269 (1997).
   PubMed Web of Science ®Google Scholar
• Pfefferbaum A, Sullivan EV, Swan GE, Carmelli D. Brain structure in men remains highly heritable in the seventh and eighth decades of life. Neurobiol. Aging21(1), 63–74 (2000).
   PubMed Web of Science ®Google Scholar
• Reveley AM, Reveley MA, Chitkara B, Clifford C. The genetic basis of cerebral ventricular volume. Psychiatry Res.13(3), 261–266 (1984).
   PubMed Web of Science ®Google Scholar
• Toga AW, Thompson PM, Sowell ER. Mapping brain maturation. Trends Neurosci.29(3), 148–159 (2006).
   PubMed Web of Science ®Google Scholar
• Keshavan MS, Diwadkar VA, Montrose DM, Rajarethinam R, Sweeney JA. Premorbid indicators and risk for schizophrenia: a selective review and update. Schizophr. Res.79(1), 45–57 (2005).
   PubMed Web of Science ®Google Scholar
• Ohara K, Sato Y, Tanabu S, Yoshida K, Shibuya H. Magnetic resonance imaging study of the ventricle-brain ratio in parents of schizophrenia subjects. Prog. Neuropsychopharmacol. Biol. Psychiatry30(1), 89–92 (2006).
   Google Scholar
• McDonald C, Marshall N, Sham PC et al. Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am. J. Psychiatry163(3), 478–487 (2006).
   PubMed Web of Science ®Google Scholar
• McIntosh AM, Job DE, Moorhead WJ et al. Genetic liability to schizophrenia or bipolar disorder and its relationship to brain structure. Am. J. Med. Genet.141(1), 76–83 (2006).
   Google Scholar
• Goghari VM, Rehm K, Carter CS, MacDonald AW 3rd. Regionally specific cortical thinning and gray matter abnormalities in the healthy relatives of schizophrenia patients. Cereb. Cortex (2006) (Epub ahead of print).
   PubMedGoogle Scholar
• van HarenNEM, Picchioni MM, McDonald C et al. A controlled study of brain structure in monozygotic twins concordant and discordant for schizophrenia. Biol. Psychiatry56(6), 454–461 (2004).
   PubMed Web of Science ®Google Scholar
• Rijsdijk FV, van Haren NEM, Picchioni MM et al. Brain MRI abnormalities in schizophrenia: same genes or same environment? Psychol. Med.35(10), 1399–1409 (2005).
   PubMed Web of Science ®Google Scholar
• Schulze K, McDonald C, Frangou S et al. Hippocampal volume in familial and nonfamilial schizophrenic probands and their unaffected relatives. Biol. Psychiatry53(7), 562–570 (2003).
   PubMed Web of Science ®Google Scholar
• van Erp TG, Saleh PA, Huttunen M et al. Hippocampal volumes in schizophrenic twins. Arch. Gen. Psychiatry61(4), 346–353 (2004).
   PubMed Web of Science ®Google Scholar
• Johnstone EC, Lawrie SM, Cosway R. What does the Edinburgh high-risk study tell us about schizophrenia? Am. J. Med. Genet.114(8), 906–912 (2002).
   PubMed Web of Science ®Google Scholar
• Keshavan MS, Jayakumar PN, Diwadkar VA, Singh A. Cavum septi pellucidi in first-episode patients and young relatives at risk for schizophrenia. CNS Spectrums7(2), 155–158 (2002).
   PubMedGoogle Scholar
• Rajarethinam R, Sahni S, Rosenberg DR, Keshavan MS. Reduced superior temporal gyrus volume in young offspring of patients with schizophrenia. Am. J. Psychiatry161(6), 1121–1124 (2004).
   PubMed Web of Science ®Google Scholar
• Diwadkar VA, Sweeney JA, Montrose DM. Cognitive impairments and structural MRI abnormalities in schizotypal first-degree relatives of schizophrenia patints. Biol. Psychiatry53(Suppl. 8), 500 (2003).
   Google Scholar
• Jou RJ, Hardan AY, Keshavan MS. Reduced cortical folding in individuals at high risk for schizophrenia: a pilot study. Schizophr. Res.75(2–3), 309–313 (2005).
   PubMed Web of Science ®Google Scholar
• van Rijn S, Aleman A, Swaab H, Kahn RS. Neurobiology of emotion and high risk for schizophrenia: role of the amygdala and the X-chromosome. Neurosci. Biobehav. Rev.29(3), 385–397 (2005).
   PubMed Web of Science ®Google Scholar
• Gilbert AR, Montrose DM, Sahni SD, Diwadkar VA, Keshavan MS. Obstetric complications correlate with neurobehavioral and brain structural alterations in young relatives at risk for schizophrenia. Ann. NY Acad. Sci.1008, 269–275 (2003).
   PubMed Web of Science ®Google Scholar
• McGlashan TH. Early detection and intervention in schizophrenia: editor's introduction. Schizophr. Bull.22(2), 197–199 (1996).
   PubMed Web of Science ®Google Scholar
• McGorry PD. ‘A stitch in time...’ The scope for preventive strategies in early psychosis. In: The Recognition and Management of Early Psychosis: A Preventive Approach. McGorry PD, Jackson HJ (Eds), Cambridge University Press, NY, USA (1999).
   Google Scholar
• Dickerson FB. Cognitive behavioral psychotherapy for schizophrenia: a review of recent empirical studies. Schizophr. Res.43(2–3), 71–90 (2000).
   PubMed Web of Science ®Google Scholar
• Job DE, Whalley HC, Johnstone EC, Lawrie SM. gray matter changes over time in high-risk subjects developing schizophrenia. NeuroImage25(4), 1023–1030 (2005).
   PubMed Web of Science ®Google Scholar
• Callicott JH. An expanded role for functional neuroimaging in schizophrenia. Curr. Opin. Neurobiol.13(2), 256–260 (2003).
   PubMed Web of Science ®Google Scholar
• Callicott JH, Bertolino A, Mattay VS et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb. Cortex10(11), 1078–1092 (2000).
   PubMed Web of Science ®Google Scholar
• Manoach DS, Halpern EF, Kramer TS et al. Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjects. Am. J. Psychiatry158(6), 955–958 (2001).
   PubMed Web of Science ®Google Scholar
• Ramsey NF, Koning HAM, Welles P, Cahn W, van der Linden JA, Kahn RS. Excessive recruitment of neural systems subserving logical reasoning in schizophrenia. Brain125(8), 1793–1807 (2002).
   PubMed Web of Science ®Google Scholar
• Callicott JH, Mattay VS, Bertolino A et al. Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb. Cortex9(1), 20–26 (1999).
   PubMed Web of Science ®Google Scholar
• Manoach DS. Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings. Schizophr. Res.60(2–3), 285–298 (2003).
   PubMed Web of Science ®Google Scholar
• Jansma JM, Ramsey NF, van der Wee NJA, Kahn RS. Working memory capacity in schizophrenia: a parametric fMRI study. Schizophr. Res.68(2–3), 159–171 (2004).
   PubMed Web of Science ®Google Scholar
• Glahn DC, Ragland JD, Abramoff A et al. Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum. Brain Mapp.25(1), 60–69 (2005).
   PubMed Web of Science ®Google Scholar
• Kumari V, Gray JA, Geyer MA et al. Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects. Psych. Res. Neuroimag.122(2), 99–113 (2003).
   PubMed Web of Science ®Google Scholar
• Hempel A, Hempel E, Schonknecht P, Stippich C, Schroder J. Impairment in basal limbic function in schizophrenia during affect recognition. Psych. Res. Neuroimag.122(2), 115–124 (2003).
   PubMed Web of Science ®Google Scholar
• Jessen F, Scheef L, Germeshausen L et al. Reduced hippocampal activation during encoding and recognition of words in schizophrenia patients. Am. J. Psychiatry160(7), 1305–1312 (2003).
   PubMed Web of Science ®Google Scholar
• Leube DT, Rapp A, Erb M et al. Hippocampal dysfunction during episodic memory encoding in patients with schizophrenia – an fMRI study. Schizophr. Res.64(1), 83–85 (2003).
   PubMed Web of Science ®Google Scholar
• Aleman A, Kahn RS. Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog. Neurobiol.77(5), 283–298 (2005).
   PubMed Web of Science ®Google Scholar
• Braus DF, Ende G, Weber-Fahr W et al. Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients. Schizophr. Res.39(1), 19–29 (1999).
   PubMed Web of Science ®Google Scholar
• Braus DF, Ende G, Hubrich-Ungureanu P, Henn FA. Cortical response to motor stimulation in neuroleptic-naive first-episode schizophrenics. Psych. Res. Neuroimag.98(3), 145–154 (2000).
   PubMed Web of Science ®Google Scholar
• Barch DM, Carter CS, Braver TS et al. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch. Gen. Psychiatry58(3), 280–288 (2001).
   PubMed Web of Science ®Google Scholar
• Muller JL, Roder C, Schuierer G, Klein HE. Subcortical overactivation in untreated schizophrenic patients: a functional magnetic resonance image finger-tapping study. Psychiatry Clin. Neurosci.56(1), 77–84 (2002).
   PubMed Web of Science ®Google Scholar
• Hofer A, Weiss EM, Golaszewski SM et al. Neural correlates of episodic encoding and recognition of words in unmedicated patients during an acute episode of schizophrenia: a functional MRI study. Am. J. Psychiatry160(10), 1802–1808 (2003).
   PubMed Web of Science ®Google Scholar
• Mendrek A, Laurens KR, Kiehl KA, Ngan ETC, Stip E, Liddle PF. Changes in distributed neural circuitry function in patients with first-episode schizophrenia. Br. J. Psychiatry185, 205–214 (2004).
   PubMed Web of Science ®Google Scholar
• Boksman K, Theberge J, Williamson P et al. A 4.0-T fMRI study of brain connectivity during word fluency in first-episode schizophrenia. Schizophr. Res.75(2–3), 247–263 (2005).
   PubMed Web of Science ®Google Scholar
• Molina V, Sanz J, Reig S et al. Hypofrontality in men with first-episode psychosis. Br. J. Psychiatry186, 203–208 (2005).
   PubMed Web of Science ®Google Scholar
• Morey RA, Inan S, Mitchell TV, Perkins DO, Lieberman JA, Belger A. Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Arch. Gen. Psychiatry62(3), 254–262 (2005).
   PubMed Web of Science ®Google Scholar
• Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc. Natl Acad. Sci. USA96(23), 13432–13437 (1999).
   PubMed Web of Science ®Google Scholar
• Miller DD, Andreasen NC, Leary DS, Watkins GL, Boles Ponto LL, Hichwa RD. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biol. Psychiatry49(8), 704–715 (2001).
   PubMed Web of Science ®Google Scholar
• Lahti AC, Holcomb HH, Weiler MA et al. Clozapine but not haloperidol re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology29(1), 171–178 (2004).
   PubMed Web of Science ®Google Scholar
• Davis CE, Jeste DV, Eyler LT. Review of longitudinal functional neuroimaging studies of drug treatments in patients with schizophrenia. Schizophr. Res.78(1), 45–60 (2005).
   PubMed Web of Science ®Google Scholar
• Gur RE, Resnick SM, Gur RC et al. Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography. Arch. Gen. Psychiatry44(2), 126–129 (1987).
   PubMed Web of Science ®Google Scholar
• Risch SC, McGurk S, Horner MD et al. A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: functional MRI correlates. Neurocase7(2), 105–110 (2001).
   PubMed Web of Science ®Google Scholar
• Nahas Z, George MS, Horner MD et al. Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study. Neurocase9(3), 274–282 (2003).
   PubMed Web of Science ®Google Scholar
• Aasen I, Kumari V, Sharma T. Effects of rivastigmine on sustained attention in schizophrenia: an fMRI Study. J. Clin. Psychopharmacol.25(4), 311–317 (2005).
   PubMed Web of Science ®Google Scholar
• Kumari V, Aasen I, Ffytche D, Williams SCR, Sharma T. Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind fMRI study. NeuroImage29(2), 545–556 (2006).
   PubMed Web of Science ®Google Scholar
• Postma P, Gray JA, Sharma T et al. A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia. Psychopharmacology (Berl).184(3–4), 589–599 (2006).
   PubMed Web of Science ®Google Scholar
• McGuire PK, Murray RM, Shah GMS. Increased blood flow in Broca’s area during auditory hallucinations in schizophrenia. Lancet342(8873), 703–706 (1993).
   PubMed Web of Science ®Google Scholar
• Suzuki M, Yuasa S, Minabe Y, Murata M, Kurachi M. Left superior temporal blood flow increases in schizophrenic and schizophreniform patients with auditory hallucination: a longitudinal case study using 123I-IMP SPECT. Eur. Arch. Psychiatry Clin. Neurosci.242(5), 257–261 (1993).
   PubMed Web of Science ®Google Scholar
• Dierks T, Linden DEJ, Jandl M et al. Activation of Heschl’s gyrus during auditory hallucinations. Neuron22(3), 615–621 (1999).
   PubMed Web of Science ®Google Scholar
• Shergill SS, Cameron LA, Brammer MJ, Williams SC, Murray RM, McGuire PK. Modality specific neural correlates of auditory and somatic hallucinations. J. Neurol. Neurosurg. Psychiatr.71(5), 688–690 (2001).
   PubMed Web of Science ®Google Scholar
• Lawrie SM, Buechel C, Whalley HC, Frith CD, Friston KJ, Johnstone EC. Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations. Biol. Psychiatry51(12), 1008–1011 (2002).
   PubMed Web of Science ®Google Scholar
• Stephane M, Barton S, Boutros NN. Auditory verbal hallucinations and dysfunction of the neural substrates of speech. Schizophr. Res.50(1–2), 61–78 (2001).
   PubMed Web of Science ®Google Scholar
• Frith CD. The cognitive neuropsychology of schizophrenia. Hillsdale, NJ, USA (1992).
   Google Scholar
• Kircher TT, Liddle PF, Brammer MJ, Williams SC, Murray RM, McGuire PK. Neural correlates of formal thought disorder in schizophrenia: preliminary findings from a functional magnetic resonance imaging study. Arch. Gen. Psychiatry58(8), 769–774 (2001).
   PubMed Web of Science ®Google Scholar
• Perlstein WM, Carter CS, Noll DC, Cohen JD. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am. J. Psychiatry158(7), 1105–1113 (2001).
   PubMed Web of Science ®Google Scholar
• Callicott JH, Egan MF, Mattay VS et al. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am. J. Psychiatry160(4), 709–719 (2003).
   PubMed Web of Science ®Google Scholar
• Thermenos HW, Seidman LJ, Breiter H et al. Functional magnetic resonance imaging during auditory verbal working memory in nonpsychotic relatives of persons with schizophrenia: a pilot study. Biol. Psychiatry55(5), 490–500 (2004).
   PubMed Web of Science ®Google Scholar
• Raemaekers M, Ramsey NF, Vink M, van den Heuvel MP, Kahn RS. Brain activation during antisaccades in unaffected relatives of schizophrenic patients. Biol. Psychiatry59(6), 530–535 (2006).
   PubMed Web of Science ®Google Scholar
• Habel U, Klein M, Shah NJ et al. Genetic load on amygdala hypofunction during sadness in nonaffected brothers of schizophrenia patients. Am. J. Psychiatry161(10), 1806–1813 (2004).
   PubMed Web of Science ®Google Scholar
• Whalley HC, Simonotto E, Flett S et al. fMRI correlates of state and trait effects in subjects at genetically enhanced risk of schizophrenia. Brain127(3), 478–490 (2004).
   PubMed Web of Science ®Google Scholar
• Whalley HC, Simonotto E, Marshall I et al. Functional disconnectivity in subjects at high genetic risk of schizophrenia. Brain128(9), 2097–2108 (2005).
   PubMed Web of Science ®Google Scholar
• Whalley HC, Simonotto E, Moorhead W et al. Functional imaging as a predictor of schizophrenia. Biol. Psychiatry (2006) (In press).
   Google Scholar
• Hariri AR, Weinberger DR. Imaging genomics. Br. Med. Bull.65, 259–270 (2003).
   Google Scholar
• Goldberg TE, Straub RE, Callicott JH et al. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology (2006) (In press).
   Google Scholar
• Egan MF, Goldberg TE, Kolachana BS et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl Acad. Sci. USA98(12), 6917–6922 (2001).
   PubMed Web of Science ®Google Scholar
• Weinberger DR, Egan MF, Bertolino A et al. Prefrontal neurons and the genetics of schizophrenia. Biol. Psychiatry50(11), 825–844 (2001).
   PubMed Web of Science ®Google Scholar
• Fan JB, Zhang CS, Gu NF et al. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol. Psychiatry57(2), 139–144 (2005).
   PubMed Web of Science ®Google Scholar
• Tunbridge EM, Harrison PJ, Weinberger DR. Catechol-O-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol. Psychiatry (2006) (In press).
   PubMedGoogle Scholar
• Blasi G, Bertolino A. Imaging genomics and response to treatment with antipsychotics in schizophrenia. NeuroRX3(1), 117–130 (2006).
   PubMedGoogle Scholar
• Pilling S, Bebbington P, Kuipers E et al. Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol. Med.32(5), 763–782 (2002).
   PubMed Web of Science ®Google Scholar